Who is sponsoring NCT03515590?

NCT03515590 is sponsored by University of Guelph.

What drugs are being tested in NCT03515590?

Interventions in NCT03515590: Emulsion with solid droplets, Emulsion with liquid droplets.

What condition does NCT03515590 study?

NCT03515590 studies Postprandial Lipemia, Satiety.

Is NCT03515590 still recruiting?

NCT03515590 is currently completed. Last updated 27 October 2020.

Last reviewed 2020-10-27 · How we verify

NCT03515590

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Emulsion Droplet Physical State on Postprandial Lipemia and Satiety

Completed NA Last updated 27 October 2020

What this trial tests

NA trial testing Emulsion with solid droplets in Postprandial Lipemia in 15 participants. Completed in 31 December 2019.

Timeline

2 July 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	University of Guelph
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	basic science
Enrollment	15
Start date	2 July 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Canada

Drugs / interventions tested

Emulsion with solid droplets
Emulsion with liquid droplets

Conditions studied

Postprandial Lipemia — all drugs for Postprandial Lipemia →
Satiety — all drugs for Satiety →

Sponsor

University of Guelph

Who can join

Adults 18 to 55, male only, with Postprandial Lipemia or Satiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the changes in blood lipids and feelings of satiety after consumption of oil-in-water emulsions in which the droplets are in either the liquid or solid (i.e. crystalline) states.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Emulsion Droplet Crystallinity Attenuates Postprandial Plasma Triacylglycerol Responses in Healthy Men: A Randomized Double-Blind Crossover Acute Meal Study.
Thilakarathna SH, Hamad S, Cuncins A, Brown M, et al · · 2020 · cited 6× · PMID 31495898 · DOI 10.1093/jn/nxz207

Verify or expand the search:

Other University of Guelph trials

Trials by the same sponsor.

NCT06186050 — Effects of a High-fat Meal on Exercise-mediated Sympatholysis · NA · completed
NCT05820256 — The Effects of Milk Protein Versus Soy Protein on Essential Omega-3 Fatty Acid Metabolism · NA · active not recruiting
NCT05958784 — PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism · NA · completed
NCT05942664 — Sleeping Habits on Performance Following Sleep Deprivation · NA · completed
NCT05514808 — An Intervention to Improve Knowledge on Dietary Supplements Among Varsity Athletes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03515590 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Guelph
Last refreshed: 27 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03515590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing